Bullish Action in Biotech Today
The melt-up resumes. Everyone talks about the really big correction but all we get is a measly 2-3% hit then onward and upward. Metals and materials were ~2% winners today and the NAZ was up 0.75%. Titanium (TIE) was up 7.9 % . What’s with that? Although healthcare was up only 0.4% there...
Rayno Snow Blog: LaNina Mid-Winter Drought
High and Dry in the West Why am I reporting on snow? There is none and little hope for the next seven days-maybe longer. If you like cool sunny dry weather come to SoCal.If you like snow go to NYC or Vancouver BC.I am booking MT for mid-February. Mammoth Lakes Weather brought to you by Howard...
Amgen(AMGN) To Buy Biovex For Cancer Vaccine Technology
Biologics for Treatment of Cancer and Prevention of Infectious Disease Amgen(AMGN) and Biovex said today that both Boards approved the sale of privately held Biovex for $425M with milestone payments as much as $525M. The Biovex lead product OncoVex, an oncolytic vaccine, is in a Phase III...
Life Science News Update:$700M in Fed Research Center at NIH; AD Diagnosis
Will the GOP cut the NIH budget? Turf battles at the Institutes to follow. Who knew there were only two breakthroughs in mental health drugs: Thorazine and Lithium? Federal Research Center Will Help Develop Medicines – NYTimes.com Most experts believe the PET Imaging procedure can be...
Biotech Movers du jour: Clinical Data (CLDA) and Genoptix (GXDX)
Novartis (NVS) acquires Genoptix(GXDX $24.84) for $470M-Stock is up 25% The biotech diagnostics and tools sector was ignited today with acquisition of Genoptix, a provider of laboratory services for hematology and oncology. Genoptix put itself up for sale in December and is an emerging niche...
